BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12908103)

  • 1. A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2003 Oct; 12(5):495-500. PubMed ID: 12908103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz H; Phillips F; Hilibrand A; Albert TJ
    Eur Spine J; 2005 Sep; 14(7):623-9. PubMed ID: 15672240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.
    Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2004 Sep; 29(17):1885-92. PubMed ID: 15534410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.
    Vaccaro AR; Anderson DG; Patel T; Fischgrund J; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
    Spine (Phila Pa 1976); 2005 Dec; 30(24):2709-16. PubMed ID: 16371892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (>4 years) pivotal study.
    Vaccaro AR; Lawrence JP; Patel T; Katz LD; Anderson DG; Fischgrund JS; Krop J; Fehlings MG; Wong D
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2850-62. PubMed ID: 19092614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study.
    Boden SD; Grob D; Damien C
    Spine (Phila Pa 1976); 2004 Mar; 29(5):504-14. PubMed ID: 15129063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Vaccaro AR, Patel T, Fischgrund J, et al. A pilot study evaluating safety and efficacy of OP-1 putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine 2004;29:1885-92.
    Bagaria V
    Spine (Phila Pa 1976); 2006 Apr; 31(7):851; author reply 851-2. PubMed ID: 16582862
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies.
    Johnsson R; Strömqvist B; Aspenberg P
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2654-61. PubMed ID: 12461391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
    Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
    Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OP-1 Compared with Iliac Crest Autograft in Instrumented Posterolateral Fusion: A Randomized, Multicenter Non-Inferiority Trial.
    Delawi D; Jacobs W; van Susante JL; Rillardon L; Prestamburgo D; Specchia N; Gay E; Verschoor N; Garcia-Fernandez C; Guerado E; Quarles van Ufford H; Kruyt MC; Dhert WJ; Oner FC
    J Bone Joint Surg Am; 2016 Mar; 98(6):441-8. PubMed ID: 26984911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative radiographic parameters be used to predict fusion in non-instrumented posterolateral fusion for degenerative spondylolisthesis?
    Agabegi SS; Majid K; Fischgrund JS; Vaccaro AR; Patel T
    Spine (Phila Pa 1976); 2011 Dec; 36(26):E1709-14. PubMed ID: 21508884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of iliac crest autograft on the outcome of fusion in the setting of degenerative spondylolisthesis: a subgroup analysis of the Spine Patient Outcomes Research Trial (SPORT).
    Radcliff K; Hwang R; Hilibrand A; Smith HE; Gruskay J; Lurie JD; Zhao W; Albert T; Weinstein J
    J Bone Joint Surg Am; 2012 Sep; 94(18):1685-92. PubMed ID: 22878599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of osteogenic protein 1: results from a prospective, randomized, controlled, multicenter pivotal study of uninstrumented lumbar posterolateral fusion.
    Hwang CJ; Vaccaro AR; Hong J; Lawrence JP; Fischgrund JS; Alaoui-Ismaili MH; Falb D
    J Neurosurg Spine; 2010 Oct; 13(4):484-93. PubMed ID: 20887146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion.
    Sandhu HS; Toth JM; Diwan AD; Seim HB; Kanim LE; Kabo JM; Turner AS
    Spine (Phila Pa 1976); 2002 Mar; 27(6):567-75. PubMed ID: 11884903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.